Sana Biotechnology's total assets for Q1 2025 were $445.47M, a decrease of -11.09% from the previous quarter. SANA total liabilities were $236.39M for the fiscal quarter, a -5.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.